Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors' Dealings notification transmitted by DGAP â a service of EQS Group AG. The person with duty of notification is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Details of the person subject to the disclosure requirement Last name: Retzlaff First name: Silvia Relationship to a person performing managerial responsibilities: Spouse or registered partner Details of the person performing managerial responsibilities Position: Member of a managing body Information about the transaction with duty of notification Description of the financial instrument: Share ISIN/WKN of the financial instrument: DE0007251803 Type of transaction: Buy Date: 17.10.2014 Price: 16.45 Currency: EUR No. of items: 400 Total amount traded: 6580.00 Place: Xetra Explanation for publication: Exercise of Option Information about the company with duty of publication Issuer: STADA Arzneimittel AG StadastraÃe 2-18 61118 Bad Vilbel Deutschland ISIN: DE0007251803 WKN: 725180 End of Directors' Dealings Notification (c) DGAP 20.10.2014 DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de ID 19701
DGAP-DD: STADA Arzneimittel AG english
| Source: EQS Group AG